Niagen Bioscience
NAGE
48 hedge funds and large institutions have $16.5M invested in Niagen Bioscience in 2016 Q2 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.28M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.52M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$1.38M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.04M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$952K |
Top Sellers
NAGE Hedge Fund Activity: Q2 2016 in Review
48 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q2 2016, worth a combined $16.5M.
Buyers outnumbered sellers: 48 funds opened new NAGE positions and 0 closed out — a net gain of 48 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $4.28M.
- 48 institutional investors held Niagen Bioscience (NAGE) as of Q2 2016, up from 0 in Q1 2016.
- Funds reported $16.5M of Niagen Bioscience stock for Q2 2016.
- 48 funds opened new Niagen Bioscience positions in Q2 2016 and 0 closed out, a net change of +48 holders.
- The largest Niagen Bioscience buyer in Q2 2016 was Vanguard Group, an estimated $4.28M added.
Based on aggregated 13F filings for Q2 2016.